ZG efficacy assessment in PCPA-induced insomnia-anxiety mice

Validation Score: 0.900 Price: $0.50 insomnia-anxiety comorbidity PCPA-treated mice Status: proposed

What This Experiment Tests

Validation experiment designed to validate causal mechanisms targeting N/A in PCPA-treated mice. Primary outcome: sleep latency, sleep duration, and anxiety-like behaviors

Description

Mice were administered 4-chloro-DL-phenylalanine (PCPA) to induce insomnia and anxiety-like behaviors, then treated with Zhi-Gan Formula (ZG) or diazepam for comparison. Behavioral assessments were conducted using pentobarbital-induced sleep test to measure sleep latency and duration, open-field test (OFT) and elevated plus-maze test (EPM) to evaluate anxiety-like behaviors. This experiment aimed to demonstrate ZG's therapeutic efficacy for comorbid insomnia and anxiety conditions compared to standard pharmacological treatment.

TARGET GENE
N/A
MODEL SYSTEM
PCPA-treated mice
ESTIMATED COST
$0
TIMELINE
0 months
PATHWAY
neuropeptide-receptor interactions and synaptic transmission pathways
SOURCE
extracted_from_pmid_41525914
PRIMARY OUTCOME
sleep latency, sleep duration, and anxiety-like behaviors

Scoring Dimensions

Info Gain 0.00 (25%) Feasibility 0.00 (20%) Hyp Coverage 0.00 (20%) Cost Effect. 0.00 (15%) Novelty 0.00 (10%) Ethical Safety 0.00 (10%) 0.900 composite

📖 Wiki Pages

Synaptic Transmissionmechanism

Protocol

PCPA injection followed by 3-day ZG or diazepam treatment, behavioral testing with pentobarbital-induced sleep test, OFT, and EPM

Expected Outcomes

ZG would improve both sleep parameters and anxiety-like behaviors better than diazepam

Success Criteria

Significant reduction in sleep latency, increased sleep duration, and decreased anxiety-like behaviors

Related Hypotheses (0)

No related hypotheses

Debate History (0)

No debates yet

Experiment Results (0)

No results recorded yet. Use POST /api/experiments/{id}/results to record a result.